Page 12 - Pharma Sector
Centre may cap trade margins for drugs in stages; companies oppose plans
While the trade margins for branded generics are standardised by trade, the margins vary in the case of unbranded generics
 "Centre may cap trade margins for drugs in stages; companies oppose plans")
Pharma sector likely to grow at 10-12% during FY19-22, outlook stable: Icra
Icra cited abating headwinds from pricing pressure in the US, stable growth for the Indian market driven by increasing healthcare spending
Stricter regulations, pricing control slow down pharma sector growth
The fifth part of the series looks at what's ailing the pharma sector
 "Stricter regulations, pricing control slow down pharma sector growth")
Dr Reddy's launches cancer treatment drug Bortezomib in the US market
Bortezomib is an active ingredient similar to that of the once blockbuster cancer treatment Velcade of Millennium Pharmaceuticals
 "Dr Reddy's launches cancer treatment drug Bortezomib in the US market")
Siddharth Mittal succeeds Arun Chandavarkar as CEO, Joint MD of Biocon
Bengaluru-headquartered biopharmaceuticals company Biocon Ltd on Tuesday said Siddharth Mittal has taken over as its chief executive officer and joint managing director. "Siddharth Mittal has taken over as Chief Executive Officer & Joint Managing Director of the company starting December 1, 2019," the company said in a BSE filing. Mittal has been serving as Chief Financial Officer (CFO) of Biocon since August 2014, the filing said. Mittal takes over from Arun Chandavarkar who retired as chief executive and joint MD of the company on November 30. "I am very pleased to welcome Siddharth as CEO & Joint MD of Biocon," Biocon CMD Kiran Mazumdar-Shaw said.
 "Siddharth Mittal succeeds Arun Chandavarkar as CEO, Joint MD of Biocon")
Indian pharma cos with bigger US presence face more FDA scrutiny: Analysts
Big entities such as Aurobindo and Dr Reddy's have been currently filing for new product approvals from multiple sites
 "Indian pharma cos with bigger US presence face more FDA scrutiny: Analysts")
Develop entire value chain: Dr Reddy's MD tells pharma companies
US-China trade war is going to give us a window of opportunity to expand our industry, says G V Prasad
 "Develop entire value chain: Dr Reddy's MD tells pharma companies")
USFDA observes major protocol lapses in Aurobindo's sterile drug unit
Regulator issues Form 483 with as many as 14 observations that could impact ongoing operations at the plant
 "USFDA observes major protocol lapses in Aurobindo's sterile drug unit")
Regulatory overhang may dent Aurobindo Pharma earnings estimate by 15-20%
The stock tanked to its five-year low before closing 8.7 per cent lower on Thursday
 "Regulatory overhang may dent Aurobindo Pharma earnings estimate by 15-20%")
Pharma Q2 Preview: Lack of new US approvals to overshadow domestic revival
Analysts expect a 12% growth in revenues for the sector
 "Pharma Q2 Preview: Lack of new US approvals to overshadow domestic revival")
Bills for pills: Antibiotics could be govt's next segment for price cap
Centre likely to consider rationalising trade margins
 "Bills for pills: Antibiotics could be govt's next segment for price cap")
India's leading drugmakers stocking up to avoid supply disruptions
Have increased raw material buffer stock by at least 40 days in recent months
 "India's leading drugmakers stocking up to avoid supply disruptions")
USFDA impact: DCGI asks states told to put antacids under scanner
The ranitidine market in India is roughly around Rs 700 crore, with about 180 brands
 "USFDA impact: DCGI asks states told to put antacids under scanner")
Biocon to set up R&D facility in India to boost biosimilars development
Biocon has acquired some assets from Pfizer Healthcare to set up its second R&D plant in India
 "Biocon to set up R&D facility in India to boost biosimilars development")
Dr Reddy's Labs shines among pharma stocks, wins investor confidence
The Hyderabad-based company is an outlier among large pharmaceutical producers, having seen a jump in its stock price over the previous year
 "Dr Reddy's Labs shines among pharma stocks, wins investor confidence")
PE majors TPG, Temasek planning investments in Indian API manufacturers
The investment interest comes as Indian drugmakers are focusing on specialty products, while relying extensively on Chinese imports for basic ingredients and other raw materials used in medicines
 "PE majors TPG, Temasek planning investments in Indian API manufacturers")
300 fresh pharma unit applications up for approval in Gujarat: FDCA
As per the state FDCA commissioner, the state has benefited from the introduction of GST
 "300 fresh pharma unit applications up for approval in Gujarat: FDCA")
Glenmark gets US health regulator nod for generic breast cancer injection
The product is a generic version of AstraZeneca Pharmaceuticals LP's Faslodex Injection in the same strength, the company said
 "Glenmark gets US health regulator nod for generic breast cancer injection")
From Dr Reddy's to Cipla, pharma companies aren't out of the woods: Experts
The Street is cautious given multiple challenges in core markets of US and India
 "From Dr Reddy's to Cipla, pharma companies aren't out of the woods: Experts")
Sun Pharma signs global licensing pact with CSIR-IICT for patents
The pact is for patents related to certain compounds with potential therapeutic activity across multiple indications
 "Sun Pharma signs global licensing pact with CSIR-IICT for patents")
